ResearchMoz

Contraceptives Market (Drugs, Devices, Pills, Hormonal & Copper IUDs, Vaginal Rings, Subdermal Implants, Topical Contraceptives, Injectables, Diaphragms, Sponges, Male & Female Condoms) - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-05-14
No. Of Pages » 93
 
 Contraceptive drugs and devices are temporary birth control methods and function majorly by altering the mechanism of ovulation and acting as physical barriers between the sperm and ovary. This report holds the market estimation of the global contraceptives market in terms of value (USD million) for the period 2012 – 2018, considering the base year 2011 as. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contraceptives market. 
   
 The overall contraceptives market is categorized on the basis of products into two major categories namely contraceptive drugs and contraceptive devices. The contraceptive drugs market is further sub-segmented into contraceptive pills, injectables and...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Growing Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
3.1.1.2 Government and NGO Initiatives to Promote Contraceptive Products
3.1.1.3 Implementation of the Patient Protection Act or the Affordable Care Act
3.1.1.4 Rising Global Prevalence of Sexually Transmitted Infections (STI)
3.1.2 Impact Analysis of Market Drivers for the Global Contraceptives Market
3.1.3 Market Restraints
3.1.3.1 Side Effects Associated with the use of Contraceptive Drugs and Devices
3.1.3.2 Rapidly Aging Population and Rising Prevalence of Infertility
3.1.4 Impact Analysis of Market Restraints for the Global Contraceptives Market
3.1.5 Market Opportunities
3.1.5.1 Presence of Strong Contraceptives Pipeline
3.1.5.1.1 Male Contraceptive Drugs
3.1.5.1.2 AG200-15 Topical Contraceptive Patch
3.1.5.1.3 FC Patch Low
3.1.5.1.4 Pill-Plus
3.1.5.1.5 Other Products in Pipeline
3.1.5.2 Presence of Large Unmet Contraceptive Needs in Emerging Asian and African Economies
3.2 Porter’s Five Forces Analysis: Global Contraceptives Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
3.4 Global Contraceptives Market, 2010 – 2018 (USD Million)

Chapter 4 Global Contraceptives Market, by Products
4.1 Overview
4.2 Global Contraceptive Drugs Market
4.2.1 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
4.2.2 Global Oral Contraceptive Pills Market
4.2.2.1 Competitive Landscape: Global Oral Contraceptives Market, 2011
4.2.2.2 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
4.2.3 Global Contraceptive Injectables Market
4.2.3.1 Competitive Landscape: Global Contraceptive Injectables Market, 2011
4.2.3.2 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
4.2.4 Global Topical Contraceptives Market
4.2.4.1 Competitive Landscape: Global Topical Contraceptives Market
4.2.4.2 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
4.3 Global Contraceptive Devices Market
4.3.1 Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.1 Competitive Landscape: Global Male Contraceptive Devices (Male Condoms) Market
4.3.1.2 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
4.3.2 Global Female Contraceptive Devices Market
4.3.2.1 Global Female Condoms Market
4.3.2.1.1 Global Female Condoms Market, 2010 – 2018 (USD Million)
4.3.2.2 Global Contraceptive Diaphragms Market
4.3.2.2.1 Global Contraceptive Diaphragms Market, 2010 – 2018 (USD Million)
4.3.2.3 Global Contraceptive Sponges Market
4.3.2.3.1 Competitive Landscape: Global Contraceptive Sponges Market
4.3.2.3.2 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
4.3.2.4 Global Contraceptive Vaginal Rings Market
4.3.2.4.1 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
4.3.2.5 Global Intrauterine Devices (IUD) Market
4.3.2.5.1 Global Copper IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.2 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
4.3.2.5.3 Competitive Landscape: Global IUD Market, 2011
4.3.2.6 Global Sub-dermal Contraceptive Implants Market
4.3.2.6.1 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
4.3.2.6.2 Competitive Landscape: Global Sub-dermal Contraceptive Implants Market

Chapter 5 Global Contraceptives Market, by Geography
5.1 Overview
5.2 North America Contraceptives Market
5.2.1 North America Contraceptives Market, 2010 – 2018 (USD Million)
5.2.2 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.3 Europe Contraceptives Market
5.3.1 Europe Contraceptives Market, 2010 – 2018 (USD Million)
5.3.2 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.4 Asia-Pacific Contraceptives Market
5.4.1 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
5.4.2 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
5.5 Rest of the World (RoW) Contraceptives Market
5.5.1 RoW Contraceptives Market, 2010 – 2018 (USD Million)
5.5.2 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

Chapter 6 Recommendations
6.1 Investing in Emerging Economies such as India and China and Underdeveloped African Economies
6.2 Making Rigorous R&D Initiatives
6.3 Investing in Marketing Campaigns to Elevate Customer Awareness
6.4 Tracking patent expiration of Branded Products

Chapter 7 Company Profiles
7.1 Merck & Co.
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategy
7.1.5 Recent Developments
7.2 Bayer  HealthCare AG
7.2.1 Company Profile
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategy
7.2.5 Recent Developments
7.3 Church & Dwight, Co. Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategy
7.3.5 Recent Developments
7.4 Warner Chilcott Company, Inc.
7.4.1 Company Profile
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategy
7.4.5 Recent Developments
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategy
7.5.5 Recent Developments
7.6 Agile Therapeutics Inc.
7.6.1 Company Overview
7.6.2 Business Strategy
7.6.3 Product Portfolio
7.6.4 Recent Developments
7.7 BioSante Pharmaceuticals Inc.
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Business Strategy
7.7.4 Product Portfolio
7.7.5 Recent Developments
7.8 Mayer Laboratories, Inc.
7.8.1 Company Overview
7.8.2 Business Strategy
7.8.3 Product Portfolio
7.8.4 Recent Developments
7.9 Pantarhei Bioscience B.V.
7.9.1 Company Overview
7.9.2 Business Strategy
7.9.3 Product Portfolio
7.9.4 Recent Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Product Portfolio
7.10.5 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Contraceptives Market
TABLE 2 Impact Analysis of Market Drivers for the Global Contraceptives Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Impact Analysis of Market Restraints for the Global Contraceptives Market
TABLE 5 Contraceptive Products in Pipeline, Product Status and Manufacturer Names
TABLE 6 Global Contraceptives Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 7 Global Contraceptives Drugs Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 8 List of Latest Oral Contraceptive Pill Approvals, 2010 – 2012
TABLE 9 Global Female Contraceptive Devices Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 10 Global IUD Market, by Product Types, 2010 – 2018 (USD Million)
TABLE 11 Global Contraceptives Market, by Geography, 2010 – 2018 (USD Million)
TABLE 12 North America Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 13 Europe Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 14 Asia-Pacific Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)
TABLE 15 RoW Contraceptives Market, by Types (Drugs & Devices), 2010 – 2018 (USD Million)

List of Figures


FIG. 1 Market Segmentation: Global Contraceptives Market
FIG. 2 Global Contraceptives Market, by Product Types, 2011 (USD Million)
FIG. 3 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 4 Average percentage of women with unmet contraceptive needs in the Southeast Asian, South Central Asian and Sub-Saharan African countries, 2011 (%)
FIG. 5 Porter’s Five Forces Analysis: Global Contraceptives Market
FIG. 7 Market Attractiveness Analysis: Global Contraceptives Market, by Geography
FIG. 8 Global Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 9 Comparative Analysis of the Global Contraceptives Market, by Products, 2011 & 2018 (%)
FIG. 10 Comparative Analysis of the Global Contraceptive Drugs Market, by Product Types, 2011 & 2018 (%)
FIG. 11 Global Contraceptive Drugs Market, 2010 – 2018 (USD Million)
FIG. 12 Competitive Landscape by Market Players: Global Oral Contraceptives Market, 2011 (%)
FIG. 13 Global Oral Contraceptive Pills Market, 2010 – 2018 (USD Million)
FIG. 14 Competitive Landscape, by Brands: Global Contraceptive Injectables Market, 2011
FIG. 15 Global Contraceptive Injectables Market, 2010 – 2018 (USD Million)
FIG. 16 Global Topical Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 17 Comparative Analysis of the Global Contraceptive Devices Market, by Product Types, 2011 & 2018 (%)
FIG. 18 Global Male Contraceptive Devices (Male Condoms) Market, 2010 – 2018 (USD Million)
FIG. 19 Global Female Condoms Market, 2010 – 2018 (USD Million)
FIG. 20 Global Female Diaphragms Market, 2010 – 2018 (USD Million)
FIG. 21 Global Contraceptive Sponges Market, 2010 – 2018 (USD Million)
FIG. 22 Global Contraceptive Vaginal Rings Market, 2010 – 2018 (USD Million)
FIG. 23 Comparative Analysis of the Global IUD Market, by Product Types, 2011 & 2018 (%)
FIG. 24 Global Copper IUD Market, 2010 – 2018 (USD Million)
FIG. 25 Global Hormonal IUD Market, 2010 – 2018 (USD Million)
FIG. 26 Global Sub-dermal Contraceptive Implants Market, 2010 – 2018 (USD Million)
FIG. 27 Comparative Analysis of the Global Contraceptives Market by Geography, 2011 & 2018 (%)
FIG. 28 North America Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 29 Europe Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 30 Asia-Pacific Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 31 RoW Contraceptives Market, 2010 – 2018 (USD Million)
FIG. 32 Annual Revenues: Merck & Co.,  2009 - 2011 (USD million)
FIG. 33 Annual Revenues: Bayer HealthCare AG., 2009 – 2011 (USD Million) (1 Euro = 1.30 USD)
FIG. 34 Annual revenues: Church & Dwight Co. Inc., 2009 – 2011 (USD Million)
FIG. 35 Annual Revenues: Warner Chilcott Co. Inc.,   2009 - 2011 (USD million)
FIG. 36 Annual revenues: Pfizer Inc., 2009 – 2011 (USD Million)
FIG. 37 Annual Revenues: BioSante Pharmaceuticals Inc., 2009 – 2011 (USD Thousands)
FIG. 38 Annual Revenues: Teva Pharmaceutical Industries Ltd., 2009 – 2011 (USD Million)

Upcoming Reports:

Obesity Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Obesity can be defined as a medical condition where excess fat deposition leads to adverse health conditions. Obesity increases the chances of diseases related with heart, certain type of cancer, diabetes and osteoarthritis. Obesity has become one of the serious leading healthcare problems across the globe. It is mainly caused by increased fatty intake, reduced physical exercises and sometimes genetic inheritance. Physical exercise and diet management are the main components for the treatment of obesity whereas anti-obesity drugs are also available for fat reduction. However, sometimes...
Greece: market of plastic tubes, pipes and hoses
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the plastic tubes, pipes and hoses market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the plastic tubes, pipes and hoses market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...
Dysautonomia (Autonomic Dysfunction) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Autonomic dysfunction or dysautonomia affects the nerve of autonomic nervous system. The autonomic system controls the function like body temperature, digestion, breathing rate, heart rate and others. It provides connection between brain and body’s internal organs like heart, eye, sweat gland and interior muscles. Dysfunction of autonomic system results adverse reaction of certain medication, disease conditions like diabetes and Parkinson’s disease and injury to the autonomic system. These conditions can be sudden or severe and develops rapid onset of symptoms. Initially...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Ford Recalls 65,000 Fusion Models Due to Issues in Ignition Key
Nov 20, 2014  
If anything defines the world of automobiles currently, it would be recalls. It seems that a flood of automobiles has surrounded the global automobiles industry, which once represented a flourishing and highly profitable industry.  The current automobile giants ordering yet another recall is Ford Motors Co. Ford declared on Tuesday that it is recalling nearly 65,000 sedans from...
3D Printed Heart Model for Better Cardiological Treatment
Nov 20, 2014  
According to research carried out by the American Heart Association’s Scientific Sessions 2014, surgeons will be able to treat complex heart disorders in patients, with the help of a three dimensional experimental printed model of the heart. For surgical planning, most cardiac surgeons make use of two dimensional images of the heart taken by MRI, ultrasound, and X-ray. But the problem is...
Los Angeles Auto Show Kicks Off
Nov 20, 2014  
The Los Angeles Auto Show kicked off on Wednesday with a rather upbeat mood. Motoring machines, industry metrics, and hybrid models – the show has lived up to its reputation once more. The Los Angeles Auto Show has begun touring North America from the Los Angeles Convention Center, and the commencement has already had an impact on the market. Gasoline prices dropped under US$3...
Scottish Government to Inject 200 Million Pounds in the Housing Sector
Nov 19, 2014  
The construction and the housing industries of Scotland will get a major financial boost from the Scottish government in terms of additional funding worth 200 million pounds. The main rationale of such a financial boost is to stimulate the housing sector and also safeguarding employment in the construction industry. The housing minister of Scotland has requested the housing leaders to work...
Quarterly Dividend of $0.10 Declared by Tyson Foods, Inc.
Nov 19, 2014  
A quarterly dividend on November 18th was declared by Tyson Foods, reported Analyst Ratings Network.com. The shareholders of the February 27th record will be awarded a dividend of 0.10 per share on March 13th.  This represents a yield of 0.94% and a $0.40 dividend on an annualized basis. However, the ex-dividend date of this particular dividend is February 25th.  Such...